Human CAR T cells with cell-intrinsic PD-1 checkpoint blockade resist tumor-mediated inhibition

10.1038/nrc971

10.1158/2159-8290.CD-12-0548

Brentjens, 2013, CD19-targeted T cells rapidly induce molecular remissions in adults with chemotherapy-refractory acute lymphoblastic leukemia, Sci Transl Med, 5, 10.1126/scitranslmed.3005930

10.1182/blood-2011-04-348540

10.1126/scitranslmed.3008226

10.1056/NEJMoa1215134

Kalos, 2011, T cells with chimeric antigen receptors have potent antitumor effects and can establish memory in patients with advanced leukemia, Sci Transl Med, 3, 10.1126/scitranslmed.3002842

10.1126/scitranslmed.3010162

Argani, 2001, Mesothelin is overexpressed in the vast majority of ductal adenocarcinomas of the pancreas: identification of a new pancreatic cancer marker by serial analysis of gene expression (SAGE), Clin Cancer Res, 7, 3862

10.1016/S0046-8177(03)00177-1

10.1186/1476-4598-5-50

10.1158/1078-0432.CCR-13-1862

10.1158/1535-7163.MCT-07-0483

10.1158/1055-9965.EPI-11-0993

10.1158/1078-0432.CCR-11-2614

10.1371/journal.pone.0114900

10.1158/2159-8290.CD-15-0583

10.1038/mt.2013.255

Spranger, 2013, Up-regulation of PD-L1, IDO, and T(regs) in the melanoma tumor microenvironment is driven by CD8(+) T cells, Sci Transl Med, 5, 10.1126/scitranslmed.3006504

10.1158/1078-0432.CCR-13-2627

10.1056/NEJMoa1003466

10.1056/NEJMoa1302369

10.1056/NEJMoa1200690

10.1007/s00262-011-1172-6

10.1126/science.aaa1348

Hamid, 2011, A prospective phase II trial exploring the association between tumor microenvironment biomarkers and clinical activity of ipilimumab in advanced melanoma, J Transl Med, 9, 10.1186/1479-5876-9-204

10.1158/1078-0432.CCR-13-0458

Strome, 2003, B7-H1 blockade augments adoptive T-cell immunotherapy for squamous cell carcinoma, Cancer Res, 63, 6501

10.1093/ejcts/ezv371

10.1158/1535-7163.MCT-08-0945

Brentjens, 2007, Genetically targeted T cells eradicate systemic acute lymphoblastic leukemia xenografts, Clin Cancer Res, 13, 5426, 10.1158/1078-0432.CCR-07-0674

Servais, 2011, Pre-clinical mouse models of primary and metastatic pleural cancers of the lung and breast and the use of bioluminescent imaging to monitor pleural tumor burden, Curr Protoc Pharmacol, Chapter 14, 10.1002/0471141755.ph1421s54

10.1371/journal.pone.0026722

10.1002/jgm.877

10.1002/1521-4141(200203)32:3<634::AID-IMMU634>3.0.CO;2-9

10.1084/jem.192.7.1027

10.1158/0008-5472.CAN-06-2098

10.1073/pnas.0915174107

10.1158/1078-0432.CCR-15-1070

10.1371/journal.pone.0077780

10.1073/pnas.0813101106

10.1158/0008-5472.CAN-10-2880

10.1182/blood-2011-05-354449

10.1158/2326-6066.CIR-13-0170

10.1084/jem.20121190

10.1084/jem.20120532

Song, 2014, Eomesodermin is required for antitumor immunity mediated by 4-1BB-agonist immunotherapy, Oncoimmunology, 3

10.1126/science.1214277

10.1038/ni.2046

10.4049/jimmunol.180.10.7028

10.4049/jimmunol.0903701

10.4049/jimmunol.1402346

10.4049/jimmunol.178.7.4650

10.4049/jimmunol.173.12.7647

10.1097/CJI.0b013e318177092b

10.1182/blood.V99.9.3179

10.1056/NEJMoa1106152

10.1182/blood-2011-02-337360

10.1016/S1470-2045(09)70074-9

10.1038/nm.3838

10.1038/nature04444

10.1073/pnas.0809818106

10.1158/0008-5472.CAN-12-3874

10.1016/bs.ai.2015.12.005

10.1038/nm827

10.1158/0008-5472.CAN-05-0436

10.1038/mt.2009.210

10.1182/blood-2009-09-241398

10.1073/pnas.0904825106

10.1097/CJI.0b013e318194a6e8

McCoy, 1973, 51 Chromium-release assay for cell-mediated cytotoxicity of human leukemia and lymphoid tissue-culture cells, Natl Cancer Inst Monogr, 37, 59